Search Within

Gregory J Riely

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (57)
  2. Meeting Abstract (27)
  3. Conference Paper (1)
Groups
  1. Department of Medicine (85)
  2. Sloan Kettering Institute Postdocs (85)
  3. Solid Tumor Oncology Division (85)
  4. Thoracic Oncology (85)
  5. GSK Faculty (80)
  6. Department of Pathology and Laboratory Medicine (76)

More Groups

People
  1. Marc Ladanyi (60)
  2. Mark Kris (45)
  3. Charles Rudin (40)
  4. Helena Yu (30)
  5. Alexander Drilon (29)
  6. Maria Arcila (28)

More People

Years
  1. 2024 (6)
  2. 2023 (14)
  3. 2022 (8)
  4. 2021 (5)
  5. 2020 (5)
  6. 2019 (13)

More Years

Publications
  1. Journal of Thoracic Oncology (16)
  2. Journal of Clinical Oncology (15)
  3. Clinical Cancer Research (14)
  4. Annals of Oncology (5)
  5. JCO Precision Oncology (5)
  6. Cancer Discovery (4)

More Publications

Publishers
  1. American Association for Cancer Research (23)
  2. American Society of Clinical Oncology (20)
  3. Elsevier Inc. (16)
  4. Nature Publishing Group (8)
  5. Oxford University Press (6)
  6. Cell Press (2)

More Publishers

Results (85)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumor mutation burden and efficacy of EGFR-tyrosine kinase inhibitors in patients with EGFR-mutant lung cancers
    Journal Article

    Offin, M.; Rizvi, H.; Tenet, M.; Ni, A.; Sanchez-Vega, F.; Li, B. T.; Drilon, A.; Kris, M. G.; Rudin, C. M.; Schultz, N.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Acquired BRAF fusions as a mechanism of resistance to EGFR therapy
    Meeting Abstract

    Vojnic, M.; Kurzatkowski, C.; Kubota, D.; Suzawa, K.; Liu, Z.; Mattar, M.; Khodos, I.; Poirier, J. T.; de Stanchina, E.; Rudin, C. M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • RET-rearranged lung cancers: Immunophenotype and response to immunotherapy
    Meeting Abstract

    Sabari, J. K.; Offin, M. D.; Wu, S. L.; Ni, A.; Halpenny, D.; Montecalvo, J.; Liu, D.; Pak, T. K.; Arbour, K. C.; Lai, W. C. V.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Tumor mutation burden and efficacy of targeted therapy in patients with EGFR mutant lung cancers
    Meeting Abstract

    Offin, M. D.; Rizvi, H.; Tenet, M.; Ni, A.; Sanchez Vega, F.; Kris, M. G.; Rudin, C. M.; Riely, G. J.; Yu, H. A.; Hellmann, M. D.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Acquired ALK and RET gene fusions as mechanisms of resistance to osimertinib in EGFR-mutant lung cancers
    Journal Article

    Offin, M.; Somwar, R.; Rekhtman, N.; Benayed, R.; Chang, J. C.; Plodkowski, A.; Lui, A. J. W.; Eng, J.; Rosenblum, M.; Li, B. T.; more...
    JCO Precision Oncology (2018)

    Fulltext@MSK | Save
  • MET exon 14-altered lung cancers: Central nervous system (CNS) metastases and patterns of CNS progression on MET inhibition
    Meeting Abstract

    Offin, M.; Dienstag, J.; Wilkins, O.; Sabari, J.; Ni, A.; Feldman, D.; Van Voorthuysen, M.; Suzawa, K.; Yu, H.; Riely, G.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Concurrent mutations in STK11 and KEAP1 is associated with resistance to PD-(L)1 blockade in patients with NSCLC despite high TMB
    Meeting Abstract

    Arbour, K.; Shen, R.; Plodkowski, A.; Rizvi, H.; Ni, A.; Long, N.; Halpenny, D.; Sanchez-Vega, F.; Rudin, C.; Riely, G.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers
    Journal Article

    Sabari, J. K.; Leonardi, G. C.; Shu, C. A.; Umeton, R.; Montecalvo, J.; Ni, A.; Chen, R.; Dienstag, J.; Mrad, C.; Bergagnini, I.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Type A thymoma presenting with bone metastasis
    Journal Article

    Montecalvo, J.; Chang, J.; Rekhtman, N.; Antonescu, C. R.; Bains, M. S.; Fabbri, N.; Plodkowski, A. J.; Riely, G. J.; Travis, W. D.; Sauter, J. L.
    Histopathology (2018)

    Fulltext@MSK | Save
  • YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics
    Journal Article

    Fan, P. D.; Narzisi, G.; Jayaprakash, A. D.; Venturini, E.; Robine, N.; Smibert, P.; Germer, S.; Yu, H. A.; Jordan, E. J.; Paik, P. K.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2018)

    Fulltext@MSK | Save